Postnatal steroids for the treatment of bronchopulmonary dysplasia: A complex case presentation

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Postnatal steroids are a controversial intervention for the prevention and treatment of bronchopulmonary dysplasia in preterm infants. Studies demonstrating a potential for steroid-related adverse effects, including growth and neurodevelopmental impairment, have significantly changed clinical practice over the past decade. There are circumstances in which the potential benefits may outweigh the risks associated with postnatal steroids. This case presentation details the hospital course and treatment plan for an extremely low-birth-weight infant who remained ventilator dependent at the age of 3 weeks. Evidence-based research, American Academy of Pediatric recommendations, and collaboration with the family helped guide the plan of care. Following a short course of low-dose dexamethasone, the infant was successfully extubated. The case highlights the importance of using clinical judgment based on research and family preferences to benefit the patient.

Original languageEnglish (US)
Pages (from-to)283-291
Number of pages9
JournalThe Journal of perinatal & neonatal nursing
Volume25
Issue number3
DOIs
StatePublished - Jul 2011
Externally publishedYes

Fingerprint

Bronchopulmonary Dysplasia
Steroids
Extremely Low Birth Weight Infant
Mechanical Ventilators
Premature Infants
Dexamethasone
Therapeutics
Pediatrics
Growth
Research

Keywords

  • bronchopulmonary dysplasia
  • chronic lung disease
  • corticosteroids
  • glucocorticoids
  • postnatal steroids
  • preterm infant

ASJC Scopus subject areas

  • Pediatrics
  • Critical Care
  • Maternity and Midwifery

Cite this

@article{27dbe5f253d648cb8ef2f606650dd457,
title = "Postnatal steroids for the treatment of bronchopulmonary dysplasia: A complex case presentation",
abstract = "Postnatal steroids are a controversial intervention for the prevention and treatment of bronchopulmonary dysplasia in preterm infants. Studies demonstrating a potential for steroid-related adverse effects, including growth and neurodevelopmental impairment, have significantly changed clinical practice over the past decade. There are circumstances in which the potential benefits may outweigh the risks associated with postnatal steroids. This case presentation details the hospital course and treatment plan for an extremely low-birth-weight infant who remained ventilator dependent at the age of 3 weeks. Evidence-based research, American Academy of Pediatric recommendations, and collaboration with the family helped guide the plan of care. Following a short course of low-dose dexamethasone, the infant was successfully extubated. The case highlights the importance of using clinical judgment based on research and family preferences to benefit the patient.",
keywords = "bronchopulmonary dysplasia, chronic lung disease, corticosteroids, glucocorticoids, postnatal steroids, preterm infant",
author = "Sharron Forest",
year = "2011",
month = "7",
doi = "10.1097/JPN.0b013e318225995c",
language = "English (US)",
volume = "25",
pages = "283--291",
journal = "The Journal of perinatal & neonatal nursing",
issn = "0893-2190",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Postnatal steroids for the treatment of bronchopulmonary dysplasia

T2 - A complex case presentation

AU - Forest, Sharron

PY - 2011/7

Y1 - 2011/7

N2 - Postnatal steroids are a controversial intervention for the prevention and treatment of bronchopulmonary dysplasia in preterm infants. Studies demonstrating a potential for steroid-related adverse effects, including growth and neurodevelopmental impairment, have significantly changed clinical practice over the past decade. There are circumstances in which the potential benefits may outweigh the risks associated with postnatal steroids. This case presentation details the hospital course and treatment plan for an extremely low-birth-weight infant who remained ventilator dependent at the age of 3 weeks. Evidence-based research, American Academy of Pediatric recommendations, and collaboration with the family helped guide the plan of care. Following a short course of low-dose dexamethasone, the infant was successfully extubated. The case highlights the importance of using clinical judgment based on research and family preferences to benefit the patient.

AB - Postnatal steroids are a controversial intervention for the prevention and treatment of bronchopulmonary dysplasia in preterm infants. Studies demonstrating a potential for steroid-related adverse effects, including growth and neurodevelopmental impairment, have significantly changed clinical practice over the past decade. There are circumstances in which the potential benefits may outweigh the risks associated with postnatal steroids. This case presentation details the hospital course and treatment plan for an extremely low-birth-weight infant who remained ventilator dependent at the age of 3 weeks. Evidence-based research, American Academy of Pediatric recommendations, and collaboration with the family helped guide the plan of care. Following a short course of low-dose dexamethasone, the infant was successfully extubated. The case highlights the importance of using clinical judgment based on research and family preferences to benefit the patient.

KW - bronchopulmonary dysplasia

KW - chronic lung disease

KW - corticosteroids

KW - glucocorticoids

KW - postnatal steroids

KW - preterm infant

UR - http://www.scopus.com/inward/record.url?scp=80051720019&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80051720019&partnerID=8YFLogxK

U2 - 10.1097/JPN.0b013e318225995c

DO - 10.1097/JPN.0b013e318225995c

M3 - Article

C2 - 21825919

AN - SCOPUS:80051720019

VL - 25

SP - 283

EP - 291

JO - The Journal of perinatal & neonatal nursing

JF - The Journal of perinatal & neonatal nursing

SN - 0893-2190

IS - 3

ER -